My belief centers around a motto: 'Infinite Responsibility, Finite Action.'
For me, infinite responsibility means actively tackling problems without constraints or avoidance. Finite action represents contemplating solutions within limited resources, acknowledging feasibility and constraints.
I am dedicated and actively exploring two key aspects of human civilization: human health and environmental conservation, the cornerstones of our existence. Contributing to solving these issues brings me immense pride and value.
Throughout my education and growth, I've cultivated three core competencies:
1. Finding innovative breakthroughs to solve problems.
2. Establishing financial sustainability for business operations.
3. Effectively transforming and commercializing innovative technologies from market, legal, and intellectual property perspectives.
These abilities allow us to achieve dreams within constraints, leveraging my experiences as an entrepreneur, manager, and investor to realize ideals. A good technology requires support from regulations and intellectual property; a good product needs marketing and communication, while a good enterprise necessitates sustainable management.
I look forward to continuing to contribute to human health and sustainable energy development. Collaborating with exceptional global innovators, entrepreneurs, and policymakers, I aim to contribute to a outstanding idea, technological discovery, and development.
Oct. 2022 - Present (1y3m)
Nutrition Care, founded in Australia in 1978, specializes in natural gastrointestinal health products and functional probiotics. Best-sellers like GUT RELIEF nutritional powder and Seasonal probiotics target seasonal rhinitis. Acquired by Ausnutria Group in 2016, it became a leading provider of gastric health products in China, expanding across major e-commerce platforms like Tmall, JD.com, Douyin, and Kuaishou.
Key Achievements:
1. Developed GASTRO REPAIR, a breakthrough product acknowledged by the Australian Therapeutic Goods Administration (TGA) for its superior effectiveness despite regulatory constraints.
2. Rectified a $3 million inventory issue within a year, addressing stockpiling and supply chain disruptions.
3. Achieved $20 million in e-commerce sales, dominating Tmall's gastric health products and monthly sales exceeding 30,000 units of probiotics on Douyin.
Aug. 2021 - Oct. 2023 (2y3m)
AU gene pioneers precision nutrition and personalized genomics, tailoring nutrition solutions based on diverse genetic profiles. Through collaboration with the Asia Advanced Medical and Research Center at China Medical University, we've developed testing methods, models, and user-friendly reports, benefiting nutrition supplement companies.
Highlights:
1. Developed a model from data of 300,000 individuals for precise outcomes.
2. Served 10,000 consumers, offering tailored recommendations for children's growth.
3. Partnered with two powdered milk brands exceeding $500 million and three nutritional supplement brands surpassing $10 million in annual revenue.
May. 2020 - Jul. 2021 (1y3m)
Ausnutria, a listed company in Hong Kong and the global leader in infant goat milk formula, prioritizes consumer experience and continual product innovation. In 2020, we ventured into precision and personalized nutrition, providing tailored solutions through individualized testing. Our initial research focuses on genomics and nutritional genomics, especially in children's growth and weight management.
Mar. 2019 - Jul 2021 (2y5m)
Averstem Therapeutics Inc., rooted in Kaohsiung Medical University since April 2017, pioneers an automated device for isolating adipose-derived stem cells. We aim for affordable, safe, same-day stem cell therapy. Our tech minimizes prep time and cell contamination risk, unlike lab methods.
Key achievements:
1. Developed a point-of-care device, transforming orthopedics and plastic surgery by condensing surgery from weeks to a day.
2. Secured four international patents, consulting the U.S. FDA for progressive regulatory approaches.
3. Expanded product development and global outreach. In Sep 2021, BioGend Therapeutics acquired Averstem, a Taiwanese advanced medical device listed company.
Aug. 2018 - Apr. 2020 (1y9m)
BioEngine Ventures, part of Centerlab Pharmaceutical Corporation, focuses on children's medication and invests in various healthcare sectors like advanced medical materials, pharmaceuticals, new drug development, health products, and nutrition.
Our notable investments:
1. Adimmune, Taiwan's sole USFDA and EMA-certified influenza vaccine manufacturer, played a crucial role during the COVID-19 outbreak, delivering returns exceeding threefold within two years.
2. XAG craft, a leading agricultural UAV company in China valued at $800 million, achieved a twofold return and plans to list in Hong Kong.
3. YIELD Hydrogen Fund, backed by Beijing Tsinghua Industrial Research Institute, targets global hydrogen energy investments. Its goals include driving China's hydrogen industry by 2030 and investing in key players like SinoHytec, the first publicly listed hydrogen energy company, and Umoe, a leading hydrogen solution provider.
Nov. 2017 - Jul. 2018 (9m)
Competitive Landscape and Industry Analysis :
・Amazon : Transformations in the retail industry driven by e-commerce and big data.
・Tesla : Developments in the electric vehicle market and the hydrogen energy industry.
・Health & Wellness : Trends in probiotics fermentation, microbiome research, and the personalized probiotics.
Jul. 2017 - Aug 2017
In 2017 program, the first intern became a employee within the company.
Feb. 2017 - Aug. 2017
Aiming to develop a swine flu detection chip compatible with a mobile app, which was selected among the top 16 outstanding entrepreneurial proposals.
Jul. 2017 - Jul. 2017
Participated in a training camp collaborating on a caregiving robot research project with Chang Gung University. The project was selected as the top-ranked topic of the year, and I was honored as an outstanding participant.
Feb. 2017 - Jul. 2017
General Biologicals is Taiwan's first company dedicated to the development and production of hepatitis testing reagents. During my internship, I assisted in the development of mouthwash products, clinical trial registration, and the development of innovative algorithmic products.
Aug. 2015 - Aug. 2015
During my internship at Bond Biotech, the Taiwan distributor for Leika Immunoassay, I participated in hospital client visits and received professional training in instrument equipment services.
2016 - 2018
2013 - 2016
My belief centers around a motto: 'Infinite Responsibility, Finite Action.'
For me, infinite responsibility means actively tackling problems without constraints or avoidance. Finite action represents contemplating solutions within limited resources, acknowledging feasibility and constraints.
I am dedicated and actively exploring two key aspects of human civilization: human health and environmental conservation, the cornerstones of our existence. Contributing to solving these issues brings me immense pride and value.
Throughout my education and growth, I've cultivated three core competencies:
1. Finding innovative breakthroughs to solve problems.
2. Establishing financial sustainability for business operations.
3. Effectively transforming and commercializing innovative technologies from market, legal, and intellectual property perspectives.
These abilities allow us to achieve dreams within constraints, leveraging my experiences as an entrepreneur, manager, and investor to realize ideals. A good technology requires support from regulations and intellectual property; a good product needs marketing and communication, while a good enterprise necessitates sustainable management.
I look forward to continuing to contribute to human health and sustainable energy development. Collaborating with exceptional global innovators, entrepreneurs, and policymakers, I aim to contribute to a outstanding idea, technological discovery, and development.
Oct. 2022 - Present (1y3m)
Nutrition Care, founded in Australia in 1978, specializes in natural gastrointestinal health products and functional probiotics. Best-sellers like GUT RELIEF nutritional powder and Seasonal probiotics target seasonal rhinitis. Acquired by Ausnutria Group in 2016, it became a leading provider of gastric health products in China, expanding across major e-commerce platforms like Tmall, JD.com, Douyin, and Kuaishou.
Key Achievements:
1. Developed GASTRO REPAIR, a breakthrough product acknowledged by the Australian Therapeutic Goods Administration (TGA) for its superior effectiveness despite regulatory constraints.
2. Rectified a $3 million inventory issue within a year, addressing stockpiling and supply chain disruptions.
3. Achieved $20 million in e-commerce sales, dominating Tmall's gastric health products and monthly sales exceeding 30,000 units of probiotics on Douyin.
Aug. 2021 - Oct. 2023 (2y3m)
AU gene pioneers precision nutrition and personalized genomics, tailoring nutrition solutions based on diverse genetic profiles. Through collaboration with the Asia Advanced Medical and Research Center at China Medical University, we've developed testing methods, models, and user-friendly reports, benefiting nutrition supplement companies.
Highlights:
1. Developed a model from data of 300,000 individuals for precise outcomes.
2. Served 10,000 consumers, offering tailored recommendations for children's growth.
3. Partnered with two powdered milk brands exceeding $500 million and three nutritional supplement brands surpassing $10 million in annual revenue.
May. 2020 - Jul. 2021 (1y3m)
Ausnutria, a listed company in Hong Kong and the global leader in infant goat milk formula, prioritizes consumer experience and continual product innovation. In 2020, we ventured into precision and personalized nutrition, providing tailored solutions through individualized testing. Our initial research focuses on genomics and nutritional genomics, especially in children's growth and weight management.
Mar. 2019 - Jul 2021 (2y5m)
Averstem Therapeutics Inc., rooted in Kaohsiung Medical University since April 2017, pioneers an automated device for isolating adipose-derived stem cells. We aim for affordable, safe, same-day stem cell therapy. Our tech minimizes prep time and cell contamination risk, unlike lab methods.
Key achievements:
1. Developed a point-of-care device, transforming orthopedics and plastic surgery by condensing surgery from weeks to a day.
2. Secured four international patents, consulting the U.S. FDA for progressive regulatory approaches.
3. Expanded product development and global outreach. In Sep 2021, BioGend Therapeutics acquired Averstem, a Taiwanese advanced medical device listed company.
Aug. 2018 - Apr. 2020 (1y9m)
BioEngine Ventures, part of Centerlab Pharmaceutical Corporation, focuses on children's medication and invests in various healthcare sectors like advanced medical materials, pharmaceuticals, new drug development, health products, and nutrition.
Our notable investments:
1. Adimmune, Taiwan's sole USFDA and EMA-certified influenza vaccine manufacturer, played a crucial role during the COVID-19 outbreak, delivering returns exceeding threefold within two years.
2. XAG craft, a leading agricultural UAV company in China valued at $800 million, achieved a twofold return and plans to list in Hong Kong.
3. YIELD Hydrogen Fund, backed by Beijing Tsinghua Industrial Research Institute, targets global hydrogen energy investments. Its goals include driving China's hydrogen industry by 2030 and investing in key players like SinoHytec, the first publicly listed hydrogen energy company, and Umoe, a leading hydrogen solution provider.
Nov. 2017 - Jul. 2018 (9m)
Competitive Landscape and Industry Analysis :
・Amazon : Transformations in the retail industry driven by e-commerce and big data.
・Tesla : Developments in the electric vehicle market and the hydrogen energy industry.
・Health & Wellness : Trends in probiotics fermentation, microbiome research, and the personalized probiotics.
Jul. 2017 - Aug 2017
In 2017 program, the first intern became a employee within the company.
Feb. 2017 - Aug. 2017
Aiming to develop a swine flu detection chip compatible with a mobile app, which was selected among the top 16 outstanding entrepreneurial proposals.
Jul. 2017 - Jul. 2017
Participated in a training camp collaborating on a caregiving robot research project with Chang Gung University. The project was selected as the top-ranked topic of the year, and I was honored as an outstanding participant.
Feb. 2017 - Jul. 2017
General Biologicals is Taiwan's first company dedicated to the development and production of hepatitis testing reagents. During my internship, I assisted in the development of mouthwash products, clinical trial registration, and the development of innovative algorithmic products.
Aug. 2015 - Aug. 2015
During my internship at Bond Biotech, the Taiwan distributor for Leika Immunoassay, I participated in hospital client visits and received professional training in instrument equipment services.
2016 - 2018
2013 - 2016